Rituximab offers a new hope for lupus patients
According to rheumatologists at the Annual European Congress of Rheumatology in Vienna, Austria, Rituximab that is presently used to treat cancer can also prove its worth when it comes to treating...
View ArticleRituximab highly effective for providing relief to lupus patients
A drug that is presently used for treating cancer may prove additional worth for treating lupus and complications of the central nervous system. Rheumatologists at the Annual European Congress of...
View ArticlePsoriasis treatment possible with lupus drug
Scientists from the University of Michigan have reported that a compound called benzodiazepine-423 (Bz-423) suppresses growth of cells in a model of psoriasis. This study available online in the...
View ArticlePatients suffering from lupus get relief with Rituximab
Rituximab, which is currently indicated to patients suffering from cancer, can also prove effective for providing relief to patients with lupus and suffering from complications of the central nervous...
View ArticleB-cell depletion therapy can help refractory patients in remaining stable
Thirty six percent of patients suffering from refractory systemic lupus erythematosus (SLE or lupus) remain well after undergoing B-cell depletion therapy (BCDT) without feeling or requiring the need...
View ArticleMysterious disease causes immune system to attack itself
Physicians at the University of Florida have found that a mysterious disease can cause immune system of the body to turn against itself besides sending a warning signal for alerting doctors at the...
View ArticleMysterious disease behind self-attack by immune system
A mysterious disease has been identified by physicians at the University of Florida. This disease leads to a self-imposed attack by the immune system on itself along with sending a warning signal to...
View ArticleLupus patients to benefit from Rituximab
A drug presently used for treating cancer patients could be used to treat patients with lupus and suffering from complications of the central nervous system, as per rheumatologists at the Annual...
View ArticleB-cell depletion therapy effective for treating refractory patients
According to a study presented at EULAR 2007, the Annual European Congress of Rheumatology in Barcelona, Spain, 36 percent of patients afflicted with refractory systemic lupus erythematosus (SLE or...
View ArticleBiological rationale behind success of steroids to treat lupus explained
The biological rationale for why large doses of corticosteroids given repeatedly over several weeks may help individuals with lupus has been uncovered by researchers at UT Southwestern Medical Center....
View Article
More Pages to Explore .....